`

Tagged: personalized medicine

BBCR works with clients beyond consulting, to create cost-effective clinical trials and strategies that nurture product strengths

November 11th, 2021 | personalized medicine

Streamlined Clinical Development Strategies Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements. Specializing in rare disease, Boston Biotech Clinical Research works with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process. […]

Small molecule mediated targeting provides alternative strategies for polypharmacology, systems biology and personalized medicine.

September 7th, 2021 | personalized medicine

Most ongoing research and clinical programs have precision medicine at the core. BBCR can assist in a number of areas in relation to precision medicine, including small molecule research, including: Strategic drug assessment Early Clinical Development Regulatory consultant FDA meeting and submission Pre-IND integrated development plan Clinical consultant Clinical study design and protocol CRO and […]

Understanding Personalized Medicine

June 26th, 2019 | personalized medicine

Patient-Centricity: Empower and inform patients making them partners in the research process

June 5th, 2019 | personalized medicine

BBCR Consulting announces the first edition of comprehensive insights into biomarker discovery and development.

May 30th, 2019 | personalized medicine
Handbook of Biomarkers

Drug development success hinges on simplifying Clinical Research

May 16th, 2019 | personalized medicine

Strategic Consulting: The convergence revolution to innovate clinical trial process

May 10th, 2019 | personalized medicine

Strategic Consulting – SCIO Process -A New Way for Drug Development

April 30th, 2019 | personalized medicine

Strategic consulting reduces cost and risk of clinical trials

April 2nd, 2019 | personalized medicine

SCIO Helps Early Stage Biotech Company Evaluation

January 24th, 2019 | personalized medicine

Pin It on Pinterest